OHSU Center for Hematologic Malignancies — Portland, Oregon

OHSU Center for Hematologic Malignancies is a clinical research site located in Portland, Oregon, United States 97239.

Crixeo Health Trust Score: 61/100 (FAIR). This profile has not yet been claimed by the site owner.

OHSU Center for Hematologic Malignancies has participated in 2 clinical trials.

Therapeutic areas: Non-Hodgkin's Lymphoma, Hodgkin Lymphoma, Multiple Myeloma.

Sponsors: Bristol-Myers Squibb, Alexion Pharmaceuticals, Inc..

Sponsor Feasibility Report

Trust Score: 61/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for OHSU Center for Hematologic Malignancies?

OHSU Center for Hematologic Malignancies has a Crixeo Trust Score of 61/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has OHSU Center for Hematologic Malignancies conducted?

OHSU Center for Hematologic Malignancies has 2 clinical trials on record. Their work covers Non-Hodgkin's Lymphoma, Hodgkin Lymphoma, Multiple Myeloma.

Is OHSU Center for Hematologic Malignancies accredited by Crixeo Health?

OHSU Center for Hematologic Malignancies has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about OHSU Center for Hematologic Malignancies?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.